Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Muso, Eri ^a   Mune, Masatoshi ^b   Fujii, Yasuhiro ^b   Imai, Enyu ^b   Ueda, Naohiko ^b   Hatta, Kazuhiro ^b   Imada, Akio ^b   Miki, Shozo ^b   Kuwahara, Takashi ^b   Takamitsu, Yoshihiro ^b   Takemura, Tsukasa ^b   Tsubakihara, Yoshiharu ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

Focal segmental glomerulosclerosis; Minimal change nephrotic syndrome; Progressive renal disease; Thromboxane B2; Tubulointerstitial injury

Indexed keywords

LOW DENSITY LIPOPROTEIN; STEROID;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; BLOOD; CLINICAL TRIAL; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEPHROTIC SYNDROME; REMISSION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; GLOMERULOSCLEROSIS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; PRIORITY JOURNAL; STEROID THERAPY;

ADOLESCENT; ADULT; BLOOD COMPONENT REMOVAL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG RESISTANCE; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTICENTER STUDIES; NEPHROTIC SYNDROME; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033043637     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. CAMERON JS, TURNER DR, OGG CS, CHANTLER C, WILLIAMS DO: The long term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218, 1978
2. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
3. D'AMICO G, GENTILE MC, MANNA G, FELLIN G, CICERI R, CONFANO F, PETRINI C, LAVARDA F, PEROLINI S, PORRINI M: Effect of vegetar-ian soy diet on hyperlipidemia in nephrotic syndrome. Lancet 339:1131-1134, 1992
4. KASISKE BL, VELOSA JA, HALSTENSON CE, LA BELLE P, LANGEN-DORFER A, KEANE WF: The effects of lovastatin in hyperlipidemic patients with nephrotic syndrome. Am J Kidney Dis 15:8-15, 1990
5. THOMPSON GR, MILLER JP, BRESLOW JL: Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. Br Med J 291:621-1673, 1985
6. MUSO E, YASHIRO M, MATSUSHIMA M, YOSHIDA H, SAWANISHI K, SASAYAMA S: Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 9:257-264, 1997
7. CARRIE BJ, GOBETZ HV, MICHAELS AS: Creatinine: An inadequate filtration marker in glomerular diseases. Am J Med 69:177-182, 1980
8. MUSO E, MUNE M, FUJII Y, IMAI E, UEDA N, HATTA K, IMADA A, MIKI S, KUWAHARA T, TAKAMITSU Y, TAKEMURA T, TSUBAKIHARA Y, KANSAI-FGS-APHERESIS TREATMENT (K-FLAT) STUDY GROUP: Significantly rapid induction of remission of steroid-resistant nephrotic syndrome by LDL-apheresis. (manuscript submitted)
9. KNISEL W, DI NICUOLO A, PFOHL M, MULLER H, RISLER T, EGOSTEIN M, SEIFRIED E: Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 234:479-487, 1993
10. KAPLAN R, AYNEDJIAN HS, SCHLONDORFF D, BANK N: Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol. J Clin Invest 86:1707-1714, 1990
11. TERKELTAUB R, BANKA CL, SOLAN J, SANTORO D, BRAND K, CURTISS LK: Oxidized LDL induced monocytic cell expression of interleukin-8, a chemokine with T-Iymphocyte chemotactic activity. Arterioscler-Thromb 14:47-53, 1994
12. YOKOYAMA K, SAKAI S, YAMAGUCHI Y, SUZUKI Y, HINOSHITA F, HARA S, YAMADA A, OGURA Y, KAWAGUCHI Y, SAKAI O: Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone. Nephron 72:318-320, 1996
13. VELOSA JA, HOLLEY KE, TORRES VE, OFFORD KP: Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58:568-577, 1983